Recital 5, Regulation (EU) 2021/2071

In force

The production and deliveries of COVID-19 vaccine doses in the Union have been accelerated and the risk that exports would threaten the execution of the Advance Purchase Agreements between the Union and the vaccine manufacturers or the security of Union supplies of COVID-19 vaccines and their active substances have currently reduced.